Overview

Evaluation of the Efficacy of Cesametâ„¢ for the Treatment of Pain in Patients With Multiple Sclerosis

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
0
Participant gender:
All
Summary
This study was designed to evaluate the safety and efficacy of Cesametâ„¢ in controlling pain in subjects experiencing pain due to Multiple Sclerosis.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
NEMA Research, Inc.
Treatments:
Nabilone
Criteria
Inclusion Criteria:

- Patients diagnosed with MS

- Chronic daily pain present for at least 2 months.

- On stable analgesic regimen for one month

- Baseline pain score greater than 40mm on a visual analog scale.

Exclusion Criteria:

- Hypersensitivity to compounds in study drug or similar drugs

- Pregnant or lactating females

- Drug or alcohol abuse

- Unstable medical condition